Johnson Matthey Pharmaceutical Materials, Inc. v. InSite Vision Incorporated
1:15-cv-00763
Overview
Parties
Defendant
InSite Vision Incorporated NPE (Individual / Inventor)
Represented By
3 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Johnson Matthey Inc. Operating Company
Represented By
6 Attorneys ListedStamoulis & Weinblatt LLC
Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor
Stamoulis & Weinblatt LLC
Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor
Plaintiff
Johnson Matthey Public Limited Company NPE (University / Research)
Represented By
2 Attorneys ListedStamoulis & Weinblatt LLC
Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor
Stamoulis & Weinblatt LLC
Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor
Johnson Matthey Pharmaceutical Materials, Inc. Operating Company
Represented By
2 Attorneys ListedStamoulis & Weinblatt LLC
Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor
Stamoulis & Weinblatt LLC
Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 7 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 4 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8299295
Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs
|
Filed: 2010-09-27
Issued: 2012-10-30
|
Active (3.9 yrs remaining)
Expires: 2030-09-27
|
|
|
US8481780
Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs
|
Filed: 2012-09-25
Issued: 2013-07-09
|
Active (5.8 yrs remaining)
Expires: 2032-09-25
|
|
|
US9045388
Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs
|
Filed: 2013-09-13
Issued: 2015-06-02
|
Active (6.8 yrs remaining)
Expires: 2033-09-13
|
|
|
US9061968
Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs
|
Filed: 2013-09-13
Issued: 2015-06-23
|
Active (6.8 yrs remaining)
Expires: 2033-09-13
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
8
Dispositive
6
Granted
0
Denied
0
Pending / Review
6
Motions by Category
Key Dispositive Motions & Rulings